Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 04 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.22 Insider Own47.19% Shs Outstand29.61M Perf Week6.26%
Market Cap287.39M Forward P/E- EPS next Y-1.01 Insider Trans-0.50% Shs Float16.55M Perf Month29.34%
Income-38.06M PEG- EPS next Q-0.26 Inst Own29.73% Short Float0.71% Perf Quarter372.68%
Sales0.33M P/S870.87 EPS this Y18.31% Inst Trans0.27% Short Ratio0.07 Perf Half Y415.17%
Book/sh2.41 P/B3.81 EPS next Y13.15% ROA-36.84% Short Interest0.12M Perf Year155.43%
Cash/sh1.47 P/C6.23 EPS next 5Y- ROE-41.70% 52W Range1.52 - 9.97 Perf YTD53.34%
Dividend Est.- P/FCF- EPS past 5Y- ROI-49.75% 52W High-8.02% Beta1.51
Dividend TTM- Quick Ratio3.51 Sales past 5Y141.42% Gross Margin-390.00% 52W Low503.29% ATR (14)0.68
Dividend Ex-Date- Current Ratio3.51 EPS Y/Y TTM19.43% Oper. Margin-12542.73% RSI (14)61.53 Volatility7.14% 8.60%
Employees89 Debt/Eq0.03 Sales Y/Y TTM44.10% Profit Margin-11534.24% Recom1.67 Target Price2.75
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q33.31% Payout- Rel Volume0.07 Prev Close9.34
Sales Surprise-57.66% EPS Surprise31.55% Sales Q/Q-51.72% EarningsNov 08 AMC Avg Volume1.68M Price9.17
SMA205.54% SMA5027.68% SMA200144.61% Trades Volume113,870 Change-1.82%
Date Action Analyst Rating Change Price Target Change
Mar-30-22Downgrade Citigroup Buy → Neutral $18 → $4
Nov-19-21Initiated Oppenheimer Outperform $19
Oct-15-21Resumed Cowen Outperform
Today 08:30AM
Feb-29-24 11:14AM
Dec-11-23 12:00PM
Dec-06-23 01:19PM
01:00PM Loading…
Nov-22-23 01:00PM
Nov-12-23 10:59AM
Nov-08-23 06:29PM
Oct-25-23 08:30AM
Sep-21-23 08:30AM
Aug-31-23 09:35AM
Aug-30-23 09:35AM
Aug-09-23 05:50PM
08:30AM Loading…
Jul-31-23 08:30AM
May-25-23 04:15PM
May-15-23 05:15PM
May-10-23 06:05PM
May-04-23 07:31AM
Apr-27-23 08:30AM
Apr-24-23 09:35AM
Mar-27-23 12:00PM
Mar-24-23 06:29AM
Mar-22-23 05:35PM
Mar-09-23 04:05PM
Feb-23-23 04:20PM
07:43AM Loading…
Feb-18-23 07:43AM
Feb-15-23 08:30AM
Nov-29-22 08:30AM
Nov-15-22 08:30AM
Nov-09-22 06:15PM
Nov-04-22 04:00PM
Oct-04-22 08:30AM
Sep-22-22 08:30AM
Sep-20-22 07:19AM
Aug-11-22 07:00AM
Aug-10-22 05:55PM
Aug-03-22 10:00AM
Jul-28-22 08:30AM
Jun-06-22 02:15PM
May-19-22 04:15PM
May-18-22 03:03PM
May-10-22 04:05PM
May-05-22 08:30AM
May-02-22 08:30AM
Apr-12-22 08:30AM
Mar-30-22 07:30AM
Mar-29-22 04:00PM
Mar-18-22 12:00PM
Mar-03-22 08:30AM
Feb-17-22 08:30AM
Feb-07-22 08:30AM
Feb-01-22 08:30AM
Dec-15-21 08:30AM
Dec-02-21 08:00AM
Dec-01-21 11:40AM
Nov-30-21 08:00AM
Nov-10-21 09:01AM
Nov-09-21 04:01PM
Nov-08-21 04:20PM
Nov-04-21 08:00AM
Nov-03-21 08:00AM
Nov-02-21 08:00AM
Oct-27-21 08:30AM
Oct-15-21 10:59AM
Sep-28-21 08:30AM
Sep-20-21 08:30AM
Sep-15-21 08:00AM
Sep-14-21 08:00AM
Sep-13-21 08:00AM
Aug-30-21 04:05PM
Aug-17-21 08:00AM
Jul-14-21 09:03PM
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lindgardt ZhenyaChief Executive OfficerFeb 06Sale8.0327,997224,816947,003Feb 07 04:56 PM
Aerts AustinChief Financial OfficerFeb 06Sale8.039,78678,582331,024Feb 07 04:56 PM
Boniface John J.Chief Scientific OfficerFeb 06Sale8.035,66545,490188,789Feb 07 04:57 PM
Jackson BenjaminGeneral CounselFeb 06Sale8.035,66545,490152,035Feb 07 04:57 PM
Harrison Robert GardnerChief Information OfficerFeb 06Sale8.035,66545,490147,835Feb 07 04:56 PM
Kearney PaulChief Data OfficerFeb 06Sale8.034,98440,022160,066Feb 07 04:56 PM
Jackson BenjaminGeneral CounselDec 07Sale5.2210,00052,200157,700Dec 07 09:35 PM
Boniface John J.Chief Scientific OfficerDec 07Sale4.805,00024,000194,454Dec 07 09:35 PM
Harrison Robert GardnerChief Information OfficerJun 05Sale3.235,00016,15028,500Jun 06 04:07 PM
Kearney PaulChief Data OfficerApr 06Option Exercise0.7524,05018,03840,050Apr 07 04:14 PM